Price
Target price
?
?
0.800%
0.1
0.800%
€10.62
07:30 / Stuttgart Stock Exchange
WKN: 897013 / Symbol: IART / Name: Integra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Integra LifeSciences Holdings Corp Stock
The Integra LifeSciences Holdings Corp stock is trending slightly upwards today, with an increase of €0.10 (0.800%) compared to yesterday's price.
With 6 Sell predictions and only 1 Buy predictions the community sentiment for Integra LifeSciences Holdings Corp is rather negative.
A potential of -20.63%, resulting from comparing the current price of 12.6 € with the target price of 10 € for Integra LifeSciences Holdings Corp, shows the chance of incurring significant losses.
Pros and Cons of Integra LifeSciences Holdings Corp in the next few years
Pros
?
C******** o* t** e**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
S********** s********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Integra LifeSciences Holdings Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Integra LifeSciences Holdings Corp | 0.800% | 1.681% | 10.000% | -35.638% | -42.925% | -75.000% | -69.598% |
| Bio-Rad Labs Inc. A | 0.740% | 4.512% | 16.720% | -9.453% | -18.879% | -48.763% | -41.290% |
| Neogen Corp. | 0.000% | -0.413% | 8.072% | -67.211% | -59.833% | - | - |
| Haemonetics Corp. | -0.860% | 1.747% | -26.614% | -30.448% | -38.278% | -38.684% | -37.450% |
Comments
Integra LifeSciences Holdings Co. (NASDAQ: IART) had its price target lowered by analysts at JPMorgan Chase & Co. from $24.00 to $12.00. They now have an "underweight" rating on the stock.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) was upgraded by analysts at Argus from a "hold" rating to a "buy" rating.
Show more
Ratings data for IART provided by MarketBeat
Integra LifeSciences Holdings Co. (NASDAQ: IART) is now covered by analysts at Morgan Stanley. They set an "underweight" rating and a $20.00 price target on the stock.
Show more
Ratings data for IART provided by MarketBeat
News
Integra (IART) Q2 Revenue Beats by 5%
Integra LifeSciences (NASDAQ:IART), a medical technology company specializing in neurosurgery, reconstructive, and tissue technologies, released its results for Q2 2025 on July 31, 2025. The most
